Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization

Infection and Immunity

Volumn 68, Issue 2, 2000, Pages 535-542

  Lukomski, Slawomir ^a   Hoe, Nancy P ^a,b   Abdi, Iman ^a   Rurangirwa, Jacqueline ^a   Kordari, Parichher ^a   Liu, Mengyao ^a,b   Dou, Shu Jun ^a   Adams, Gerald G ^a   Musser, James M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIUM ISOLATION; MALE; MOUSE; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; UPPER RESPIRATORY TRACT INFECTION;

ANIMALS; BACTERIAL PROTEINS; COMPLEMENT INACTIVATOR PROTEINS; HUMANS; MALE; MICE; MUTATION; PHARYNX; SEROTYPING; STREPTOCOCCUS PYOGENES;

EID: 0033955513     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.2.535-542.2000     Document Type: Article

References (32)

1. Akesson, P., A. G. Sjoholm, and L. Bjorck. 1996. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J. Biol. Chem. 271:1081-1088.
2. Beall, B., R. Facklam, T. Hoenes, and B. Schwartz. 1997. Survey of emmgene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J. Clin. Microbiol. 35:1231-1235.
3. Betschel, S. D., S. M. Borgia, N. L. Barg, D. E. Low, and J. C. S. de Azavedo. 1998. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect. Immun. 66:1671-1679.
4. Chen, C. C., and P. P. Cleary. 1990. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J. Biol. Chem. 265:3161-3167.
5. Cockerill, F. R., III, K. L. MacDonald, R. L. Thompson, F. Roberson, P. C. Kohner, J. Besser-Wiek, J. M. Manahan, J. M. Musser, P. M. Schlievert, J. Talbot, B. Frankfort, J. M. Steckelberg, W. R. Wilson, M. T. Osterholm, and the Investigation Team. 1997. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 277:38-43.
6. Diederich, L., A. Roth, and W. Messer. 1994. A versatile plasmid vector system for the regulated expression of genes in Escherichia coli. BioTechniques 16:916-923.
7. Fedorova, N. D., and S. K. Highlander. 1997. Generation of targeted non-polar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin. Infect. Immun. 65:2593-2598.
8. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2:285-314.
9. Harbaugh, M. P., A. Podbielski, S. Hugl, and P. P. Cleary. 1993. Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein. Mol. Microbiol. 8:981-991.
10. Hoe, N. P., K. Nakashima, S. Lukomski, D. Grigsby, M. Liu, P. Kordari, S.-J. Dou, X. Pan, J. Vuopio-Varkila, S. Salmenlinna, A. McGeer, D. E. Low, B. Schwartz, A. Schuchat, S. Naidich, D. De Lorenzo, Y.-X. Fu, and J. M. Musser. 1999. Rapid selection of structural variants of group A Streptococcus complement-inhibiting protein in serotype M1 epidemic waves. Nat. Med. 5:924-929.
11. Ji, Y., B. Carlson, A. Kondagunta, and P. P. Cleary. 1997. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect. Immun. 65:2080-2087.
12. Ji, Y., L. McLandsborough, A. Kondagunta, and P. P. Cleary. 1996. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64:503-510.
13. Ji, Y., N. Schnitzler, E. DeMaster, and P. Cleary. 1998. Impact of M49. Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes. Infect. Immun. 66:5399-5405.
14. Kihlberg, B. M., J. Cooney, M. G. Caparon, A. Olsen, and L. Bjorck. 1995. Biological properties of a Streptococcus pyogenes mutant generated by Tn916 insertion in mga. Microb. Pathog. 19:299-315.
15. Larsen, J. E. L., K. Gerdes, J. Light, and S. Molin. 1984 Low-copy-number plasmid-cloning vectors amplifiable by derepression of an inserted foreign promoter. Gene 28:45-54.
16. LeBlanc, D. J., L. N. Lee, and J. M. Inamine. 1991. Cloning and nucleotide base sequence analysis of a spectinomycin adenyltransferase Aad(9) determinant from Enterococcus faecalis. Antimicrob. Agents Chemother. 35: 1804-1810.
17. Lukomski, S., R. A. Hull, and S. I. Hull. 1996. Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 by insertional mutagenesis using a nonpolar chloramphenicol resistance cassette. J. Bacteriol. 178:240-247.
18. Lukomski, S., C. A. Montgomery, J. Rurangirwa, R. S. Geske, J. P. Barrish, G. J. Adams, and J. M. Musser. 1999. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect. Immun. 67:1779-1788.
19. Martin, D. R., and L. A. Single. 1993. Molecular epidemiology of group A streptococcus M type 1 infections. J. Infect. Dis. 167:1112-1117.
20. Menard, R., P. J. Sansonetti, and C. Parsot. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 174:5899-5906.
21. Muotiala, A., H. Seppala, P. Huovinen, and J. Vuopio-Varkila. 1997. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J. Infect. Dis. 175:392-399.
22. Musser, J. M., V. Kapur, J. Szeto, X. Pan, D. S. Swanson, and D. R. Martin. 1995. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63:994-1003.
23. Musser, J. M., and R. M. Krause. 1998. The revival of group A streptococcal diseases with a commentary on staphylococcal toxic shock syndrome, p. 185-218. In R. M. Krause and A. Fauci (ed.), Emerging infections. Academic Press, San Diego, Calif.
24. Norgren, M., M. G. Caparon, and J. R. Scott. 1989. A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4. Infect. Immun. 57:3846-3850.
25. Perez-Casal, J. F., H. F. Dillon, L. K. Husmann, B. Graham, and J. R. Scott. 1993. Virulence of two Streptococcus pyogenes strains (types M1 and M3) associated with toxic-shock-like syndrome depends on an intact mry-like gene. Infect. Immun. 61:5426-5430.
26. Podbielski, A., B. Pohl, M. Wolschnik, C. Korner, K. H. Schmidt, E. Rozdzinski, and B. A. B. Leonard. 1996. Molecular characterization of the group A streptococcal (GAS) oligopeptide permease (Opp) and its effect on cysteine protease production. Mol. Microbiol. 21:1087-1099.
27. Podbielski, A., B. Spellerberg, M. Woischnik, B. Pohl, and R. Lutticken. 1996. Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene 177:137-147.
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Plainview. N.Y.
29. Stockbauer, K. E., D. Grigsby, X. Pan, Y.-X. Fu, L. M. Perea Mejia, A. Cravioto, and J. M. Musser. 1998. Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. Proc. Natl. Acad. Sci. USA 95:3128-3133.
30. Tao, L., S. K. Hollingshead, A. N. Suvorov, J. J. Ferretti, and W. M. McShan. 1995. Construction of a Streptococcus pyogenes recA mutant via insertional inactivation, and cloning and sequencing of the complete recA gene. Gene 162:59-62.
31. Tao, L., D. J. LeBlanc, and J. J. Ferretti. 1992. Novel streptococcal-integration shuttle vectors for gene cloning and inactivation. Gene 120:105-110.
32. Wessels, M. R., A. E. Moses, J. B. Goldberg, and T. J. DiCesare. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA 88:8317-8321.